{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:56:37Z","timestamp":1794333397174,"version":"4.9.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC3604402"],"award-info":[{"award-number":["2023YFC3604402"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,27]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Sepsis affects millions of people and imposes a substantial economic and social burden worldwide. However, the role of human albumin in the management of septic patients remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>EMBASE, PubMed, and Cochrane Library databases were searched. Randomized controlled trials regarding the use of human albumin in septic patients were eligible. The overall mortality and the intensive care unit (ICU), in-hospital\/28-day, and 90-day mortality were pooled, respectively. Subgroup analyses were performed according to target population, type and dose of human albumin, and type of control group. Risk ratios (RRs) was calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-four randomized controlled trials were finally included. Meta-analysis showed that human albumin cannot decrease the overall (RR\u2005=\u20051.02,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.56), ICU (RR\u2005=\u20051.06,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.65), in-hospital\/28-day (RR\u2005=\u20051.01,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.68), and 90-day (RR\u2005=\u20051.01,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.65) mortality of total patients. Subgroup analyses showed that human albumin both cannot significantly decrease the overall, ICU, in-hospital\/28-day, and 90-day mortality of sepsis and septic patients. Additionally, 20% human albumin (RR\u2005=\u20050.89,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.03) and high daily dose of human albumin (RR\u2005=\u20050.90,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.03) might benefit for the survival of patients with septic shock.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Based on the current evidence, the general use of human albumin to improve the survival of septic patients cannot be recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000040983","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T21:01:13Z","timestamp":1735592473000},"page":"e40983","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Human albumin for adults with sepsis: An updated systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1097","volume":"103","author":[{"given":"Zhaohui","family":"Bai","sequence":"first","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China"},{"name":"International Research Center for Medicinal Administration, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China"},{"name":"International Research Center for Medicinal Administration, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1074-608X","authenticated-orcid":false,"given":"Yang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China"},{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R3-20260911","article-title":"World Health Assembly 70, Resolution 70.7: improving the prevention, diagnosis and clinical management of sepsis.","year":"2017"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.3390\/ijms221810086","article-title":"Serum albumin: a multifaced enzyme.","volume":"22","author":"De Simone","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.20720","article-title":"Albumin: biochemical properties and therapeutic potential.","volume":"41","author":"Quinlan","year":"2005","journal-title":"Hepatology"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin.","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives.","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00134-010-2039-6","article-title":"Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis.","volume":"37","author":"Finfer","year":"2011","journal-title":"Intensive Care Med"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock.","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12072-021-10164-z","article-title":"Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial.","volume":"15","author":"Philips","year":"2021","journal-title":"Hepatol Int"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00003246-198905000-00003","article-title":"Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion.","volume":"17","author":"Rackow","year":"1989","journal-title":"Crit Care Med"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(05)60602-2","article-title":"Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock.","volume":"351","author":"Abraham","year":"1998","journal-title":"Lancet"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/CCM.0b013e3181ffe217","article-title":"The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis.","volume":"39","author":"Delaney","year":"2011","journal-title":"Crit Care Med"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"g4561","DOI":"10.1136\/bmj.g4561","article-title":"Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality.","volume":"349","author":"Patel","year":"2014","journal-title":"BMJ"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1186\/s13054-014-0702-y","article-title":"Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials.","volume":"18","author":"Xu","year":"2014","journal-title":"Crit Care"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40560-021-00555-7","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020).","volume":"9","author":"Egi","year":"2021","journal-title":"J Intensive Care"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"106591","DOI":"10.1016\/j.ijantimicag.2022.106591","article-title":"Epidemiology and age-related mortality in critically ill patients with intra-abdominal infection or sepsis: an international cohort study.","volume":"60","author":"Arvaniti","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00134-009-1427-2","article-title":"Arterial blood pressure during early sepsis and outcome.","volume":"35","author":"D\u00fcnser","year":"2009","journal-title":"Intensive Care Med"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13054-023-04587-3","article-title":"Identification of indications for albumin administration in septic patients with liver cirrhosis.","volume":"27","author":"Hu","year":"2023","journal-title":"Crit Care"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot.","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"key":"R24-20260911","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"R25-20260911","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"Int J Epidemiol"},{"key":"R26-20260911","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R27-20260911","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R28-20260911","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00003246-198311000-00001","article-title":"Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock.","volume":"11","author":"Rackow","year":"1983","journal-title":"Crit Care Med"},{"key":"R29-20260911","first-page":"787","article-title":"Anti-endotoxin in the treatment of severe surgical septic shock. Results of a randomized double-blind trial.","volume":"68","author":"Aitchison","year":"1985","journal-title":"S Afr Med J"},{"key":"R30-20260911","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/archsurg.1991.01410260126018","article-title":"Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater.","volume":"126","author":"Dominioni","year":"1991","journal-title":"Arch Surg"},{"key":"R31-20260911","first-page":"76","article-title":"Effects of immunuglobulin G on surgical sepsis and septic shock.","volume":"40","author":"Yakut","year":"1998","journal-title":"Bull Gulhane Mil Med Acad"},{"key":"R32-20260911","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/cc1070","article-title":"Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients.","volume":"5","author":"Fernandes","year":"2001","journal-title":"Crit Care"},{"key":"R33-20260911","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"High-dose antithrombin III in severe sepsis: a randomized controlled trial.","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"R34-20260911","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.shk.0000157302.69125.f8","article-title":"Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery.","volume":"23","author":"Rodr\u00edguez","year":"2005","journal-title":"Shock"},{"key":"R35-20260911","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/cc5098","article-title":"Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis.","volume":"10","author":"Gonano","year":"2006","journal-title":"Crit Care"},{"key":"R36-20260911","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.CCM.0000215452.84291.C6","article-title":"IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.","volume":"34","author":"Hentrich","year":"2006","journal-title":"Crit Care Med"},{"key":"R37-20260911","first-page":"655","article-title":"The effects of hydroxyethyl starch solution in critically ill patients.","volume":"72","author":"Palumbo","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"R38-20260911","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/01.CCM.0000230385.82679.34","article-title":"Safety and efficacy of affinity-purified, anti-tumor necrosis factor-\u03b1, ovine fab for injection (CytoFab) in severe sepsis.","volume":"34","author":"Rice","year":"2006","journal-title":"Crit Care Med"},{"key":"R39-20260911","first-page":"2693","article-title":"Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study.","volume":"35","author":"Werdan","year":"2007","journal-title":"Crit Care Med"},{"key":"R40-20260911","first-page":"1622","article-title":"Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial.","volume":"56","author":"Dolecek","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"R41-20260911","first-page":"S115","article-title":"Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study.","volume":"37","author":"Charpentier","year":"2011","journal-title":"Intensive Care Med"},{"key":"R42-20260911","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2013.280502","article-title":"Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial.","volume":"310","author":"Annane","year":"2013","journal-title":"JAMA"},{"key":"R43-20260911","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial.","volume":"62","author":"Th\u00e9venot","year":"2015","journal-title":"J Hepatol"},{"key":"R44-20260911","first-page":"8","article-title":"Albumin as a resuscitative fluid in patients with severe sepsis: a randomized clinical trial.","volume":"5","author":"Kakaei","year":"2017","journal-title":"ABC Med"},{"key":"R45-20260911","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1097\/CCM.0000000000003900","article-title":"Lactated ringer\u2019s versus 4% albumin on lactated ringer\u2019s in early sepsis therapy in cancer patients: a pilot single-center randomized trial.","volume":"47","author":"Park","year":"2019","journal-title":"Crit Care Med"},{"key":"R46-20260911","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2022.03.043","article-title":"A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial].","volume":"77","author":"Maiwall","year":"2022","journal-title":"J Hepatol"},{"key":"R47-20260911","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/08850666231170778","article-title":"Different concentrations of albumin versus crystalloid in patients with sepsis and septic shock: a meta-analysis of randomized clinical trials.","volume":"38","author":"Geng","year":"2023","journal-title":"J Intensive Care Med"},{"key":"R48-20260911","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00003246-198203000-00004","article-title":"Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions.","volume":"10","author":"Haupt","year":"1982","journal-title":"Crit Care Med"},{"key":"R49-20260911","first-page":"207","article-title":"Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency.","volume":"158","author":"Metildi","year":"1984","journal-title":"Surg Gynecol Obstet"},{"key":"R50-20260911","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/CCM.0b013e31819cedfd","article-title":"Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia.","volume":"37","author":"van der Heijden","year":"2009","journal-title":"Crit Care Med"},{"key":"R51-20260911","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00134-010-1776-x","article-title":"Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia.","volume":"36","author":"Trof","year":"2010","journal-title":"Intensive Care Med"},{"key":"R52-20260911","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200401000-00012","article-title":"Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium.","volume":"100","author":"Lang","year":"2004","journal-title":"Anesthesiology"},{"key":"R53-20260911","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/cs0950459","article-title":"Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion.","volume":"95","author":"Quinlan","year":"1998","journal-title":"Clin Sci (Lond)"},{"key":"R54-20260911","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock.","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"R55-20260911","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00134-008-1225-2","article-title":"The risk associated with hyperoncotic colloids in patients with shock.","volume":"34","author":"Schortgen","year":"2008","journal-title":"Intensive Care Med"},{"key":"R56-20260911","first-page":"122","article-title":"Haemodynamic and biochemical responses to fluid bolus therapy with human albumin solution, 4% versus 20%, in critically ill adults.","volume":"17","author":"Bannard-Smith","year":"2015","journal-title":"Crit Care Resusc"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000040983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:03:22Z","timestamp":1789142602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000040983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":56,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040983","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}